Glutathione-S-Transferase P1 Isoenzyme Polymorphisms, Platinum-Based Chemotherapy, and Non-small Cell Lung Cancer
![Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth | Journal of Medicinal Chemistry Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b00463/asset/images/large/jm-2016-00463p_0018.jpeg)
Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth | Journal of Medicinal Chemistry
![Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment](https://www.mdpi.com/cancers/cancers-13-05414/article_deploy/html/images/cancers-13-05414-g001.png)
Cancers | Free Full-Text | Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy
![Rapid induction of apoptosis in tumor cells treated with a new platinum(II) complex based on amino-thiazolidinone - ScienceDirect Rapid induction of apoptosis in tumor cells treated with a new platinum(II) complex based on amino-thiazolidinone - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S022352341830641X-fx1.jpg)
Rapid induction of apoptosis in tumor cells treated with a new platinum(II) complex based on amino-thiazolidinone - ScienceDirect
![Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02141-z/MediaObjects/13046_2021_2141_Fig1_HTML.png)
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text
Nanotechnology Approaches for Prevention and Treatment of Chemotherapyâ•'Induced Neurotoxicity, Neuropathy, and Cardiomyopa
![Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02141-z/MediaObjects/13046_2021_2141_Fig2_HTML.png)
Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development | Journal of Experimental & Clinical Cancer Research | Full Text
![Clinical development of platinum complexes in cancer therapy: an historical perspective and an update - ScienceDirect Clinical development of platinum complexes in cancer therapy: an historical perspective and an update - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980499800224X-gr1.gif)